Descripción de la empresa
Guardian Pharmacy Services, Inc. operates as a specialized pharmacy service company dedicated to providing technology-enabled clinical, drug dispensing, and administration capabilities to residents within long-term health care facilities across the United States. The enterprise functions within the Healthcare sector, specifically categorized under the Medical Care Facilities industry, positioning it as a critical provider of essential pharmaceutical support services to institutional settings. At a macro level, the company commands a market capitalization of $2.53B and generates annual revenue of $1.45B, while maintaining an operational workforce of 3,600 employees. These aggregate figures indicate that Guardian Pharmacy Services has established a significant footprint in the fragmented long-term care market, reflecting a substantial scale that allows for broad service delivery and considerable influence within its specific niche of medical care facilities.
Salud financiera
The financial performance of the company over the trailing twelve months demonstrates a revenue generation of $1.45B, which supports a net income of $49.22M and an EBITDA of $102.62M. The substantial disparity between the $1.45B revenue and the $49.22M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative overhead, consume approximately 96.6% of total revenue before interest and taxes. The company produces a free cash flow of $73.88M, a metric that signifies robust financial flexibility enabling the firm to service its obligations, invest in operational technology, or weather potential economic downturns without immediate liquidity distress. Margin analysis highlights a gross margin of 20.2%, suggesting moderate profitability on the sale of pharmaceutical goods; an operating margin of 8.9% indicates efficient management of operating costs relative to revenue; and a profit margin of 3.4% reflects the final bottom-line profitability after all expenses are accounted for. Regarding balance sheet strength, the company holds $65.62M in cash against $44.72M in debt, resulting in a debt-to-equity ratio of 20.52, which suggests a highly leveraged capital structure relative to its equity base. Liquidity is assessed via a current ratio of 1.38, indicating that the company possesses sufficient short-term assets to cover its current liabilities with a comfortable buffer. Return metrics show a Return on Equity of 26.6% and a Return on Assets of 13.7%, figures that reveal management is highly effective at utilizing shareholder capital and total assets to generate earnings, despite the leverage present on the balance sheet.
Evaluación de valoración
Valuation multiples for Guardian Pharmacy Services, Inc. show a P/E Ratio (TTM) of 50.33 compared to a Forward P/E of 29.00, a significant divergence that implies the market expects a dramatic improvement in earnings trajectory to justify the current multiple over the next year. The price-to-book ratio stands at 12.08, indicating that the market is pricing the company at a heavy premium of over eleven times its book value, likely reflecting intangible assets or growth expectations rather than tangible asset backing. Alternative valuation metrics such as the price-to-sales ratio of 1.74 and an EV/EBITDA of 24.14 provide additional context, suggesting the stock is valued at nearly double its sales and at a premium multiple relative to its operating cash generation capabilities. Price action over the last year has seen the stock trade between a 52-week high of $39.53 and a 52-week low of $19.17, placing the current valuation within a wide historical range where the price has experienced substantial volatility. The beta value is listed as N/A in available data, meaning that standard volatility metrics relative to the broader market are not currently disclosed or applicable for this specific reporting period.
Growth & Income
Revenue growth for the trailing twelve months has accelerated to 17.4%, while earnings growth data is marked as N/A, preventing a direct comparison of earnings expansion against revenue expansion. Since earnings growth is not explicitly quantified in the provided facts, the relationship between the two cannot be mathematically determined, though the robust revenue expansion suggests top-line momentum in the long-term care pharmacy segment. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that the firm retains all of its net income to fund operations, debt reduction, or potential reinvestment rather than distributing cash to shareholders. Consequently, the overall growth and income profile for Guardian Pharmacy Services, Inc. is characterized by a pure growth strategy without income distribution, relying entirely on capital appreciation and revenue expansion to deliver shareholder value.